Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)

NCT00027391 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

160

Enrollment

FED

Sponsor class

Conditions

Muscular Dystrophies

Interventions

DRUG: Albuterol
DRUG: Oxandrolone

Sponsor

FDA Office of Orphan Products Development